https://european-biotechnology.net/wp-content/uploads/2024/10/Rentschler-Biopharma_150516_0186_Nukleus.jpg
540
960
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-24 05:30:102024-10-24 05:30:10Rentschler with double-digit investment in Germany
https://european-biotechnology.net/wp-content/uploads/2024/10/Roche3-1030x583-1.png
583
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-23 09:32:172024-10-23 09:32:17Roche leaves Alzheimer partnership with UCB
https://european-biotechnology.net/wp-content/uploads/2024/10/2024-10-22_dr-michael-chen-standing-with-eprotein-discovery-holding-smart-cartridge-2048x1196-1-1030x602-1.jpg
602
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-22 10:43:352024-10-22 13:32:02Nuclera Secures US$75m to Advance Protein Discovery System
https://european-biotechnology.net/wp-content/uploads/2024/10/representation-human-dna-chain-1030x579-1.jpg
579
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-21 10:04:572024-10-21 10:04:57Purespring bags £80m to transform kidney disease treatment
https://european-biotechnology.net/wp-content/uploads/2024/10/WHS_Feature_2024_990-1030x686-1.jpg
686
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-18 12:59:082024-10-18 12:59:08WHO: One billion US$ for global health
https://european-biotechnology.net/wp-content/uploads/2024/10/ikerian-1030x584-1.png
584
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-16 13:25:442024-10-16 13:25:44Swiss Ikerian AG partner with Sanoptis Inc to market AI-image analysis
https://european-biotechnology.net/wp-content/uploads/2024/10/Molcure-e1729083269678-1030x578-1.png
578
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-16 12:55:562024-10-16 12:55:56Antibody developer Yumab partners with Japanese AI specialist Molcure
https://european-biotechnology.net/wp-content/uploads/2024/10/forbion_©verwol-1030x688-1.jpg
688
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-15 08:14:112024-10-15 08:14:11Forbion raises more than €2bn for two new funds
https://european-biotechnology.net/wp-content/uploads/2024/10/Lundbecks-headquarters-in-Valby-e1728977732319-1030x580-1.jpeg
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-15 07:36:572024-10-15 07:36:57Lundbeck to take over Longboard Pharma in US$2.6bn transaction
https://european-biotechnology.net/wp-content/uploads/2024/10/PenkidMOA.png
326
554
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-09 08:57:572024-10-09 08:57:57Sphingotec licenses kidney function test
Scroll to top
